Cunningham Joan, Sales Mark, Pearce Andrew, Howard Julie, Stallings Ray, Telford Nicholas, Wilkie Rosalie, Huntly Brian, Thomas Angela, O'Marcaigh Aengus, Will Andrew, Pratt Norman
Ninewells Hospital and Medical School, Dundee, Western General Hospital, Edinburgh, UK.
Br J Haematol. 2002 Dec;119(4):1062-9. doi: 10.1046/j.1365-2141.2002.03940.x.
We report on nine children with Shwachman-Diamond syndrome (SDS), eight of whom had clonal abnormalities of chromosome 7. Seven children had an isochromosome 7 [i(7)(q10)] and one a derivative chromosome 7, all with an apparently identical (centromeric) breakpoint. Children with SDS are predisposed to myelodysplasia (MDS) and acute myeloid leukaemia (AML) often with chromosome 7 abnormalities. Allogeneic transplants have been used to treat these children, however, they are a high-risk transplant group and require careful evaluation. Three of the children were transplanted but only one survived, who to our knowledge remains the longest surviving SDS transplant patient (4.5 years +). The six non-transplanted children are well. In classic MDS, chromosome 7 abnormalities are associated with rapid progression to acute leukaemia; however, we present evidence to suggest that isochromosome 7q may represent a separate disease entity in SDS children. This is a particularly interesting finding given that the SDS gene has recently been mapped to the centromeric region of chromosome 7. Our studies indicate that i(7)(q10) is a relatively benign rearrangement and that it is not advisable to offer allogeneic transplants to SDS children with i(7)(q10) alone in the absence of other clinical signs of disease progression.
我们报告了9例施瓦赫曼-戴蒙德综合征(SDS)患儿,其中8例存在7号染色体的克隆异常。7例患儿有7号等臂染色体[i(7)(q10)],1例有衍生7号染色体,所有这些染色体的(着丝粒)断点明显相同。SDS患儿易患骨髓增生异常综合征(MDS)和急性髓系白血病(AML),常伴有7号染色体异常。异基因移植已被用于治疗这些患儿,然而,他们是高风险移植群体,需要仔细评估。3例患儿接受了移植,但只有1例存活,据我们所知,这仍是存活时间最长的SDS移植患者(4.5年以上)。6例未移植的患儿情况良好。在经典MDS中,7号染色体异常与快速进展为急性白血病相关;然而,我们提供的证据表明,7号等臂染色体q可能代表SDS患儿中的一种独立疾病实体。鉴于SDS基因最近已被定位到7号染色体的着丝粒区域,这是一个特别有趣的发现。我们的研究表明,i(7)(q10)是一种相对良性的重排,在没有其他疾病进展临床迹象的情况下,仅对有i(7)(q10)的SDS患儿进行异基因移植是不可取的。